MOGOMOTSI MATSHABA to Child
This is a "connection" page, showing publications MOGOMOTSI MATSHABA has written about Child.
Connection Strength
0.312
-
Challenges and coping strategies among young adults living with perinatally acquired HIV infection in Botswana. A qualitative study. PLoS One. 2023; 18(4):e0284467.
Score: 0.050
-
The barriers and facilitators of HIV-exposed infant testing as perceived by HIV-positive mothers in Botswana: A qualitative study. PLoS One. 2022; 17(8):e0273777.
Score: 0.048
-
Food insecurity and CD4% Among HIV+ children in Gaborone, Botswana. J Acquir Immune Defic Syndr. 2014 Aug 01; 66(4):414-8.
Score: 0.027
-
Long-term non-progression and risk factors for disease progression among children living with HIV in Botswana and Uganda: A retrospective cohort study. Int J Infect Dis. 2024 Feb; 139:132-140.
Score: 0.013
-
Stunted Growth Is Associated With Dyslipidemia in Young Adults With Perinatal HIV Infection. J Acquir Immune Defic Syndr. 2023 08 01; 93(4):343-350.
Score: 0.013
-
Test-Retest Reliability of a Computerized Neurocognitive Battery in School-Age Children with HIV in Botswana. Arch Clin Neuropsychol. 2023 Jan 21; 38(1):131-138.
Score: 0.012
-
Optimal Timing of Antiretroviral Therapy Initiation in Children and Adolescents With Human Immunodeficiency Virus-Associated Pulmonary Tuberculosis. Clin Infect Dis. 2023 01 06; 76(1):10-17.
Score: 0.012
-
Risk factors and prognostic significance of platelet count abnormalities in children with HIV infection on antiretroviral therapy. AIDS. 2023 03 01; 37(3):413-421.
Score: 0.012
-
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy. AIDS. 2022 12 01; 36(15):2139-2146.
Score: 0.012
-
Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis. J Int AIDS Soc. 2022 03; 25(3):e25871.
Score: 0.012
-
Predictive Validity of a Computerized Battery for Identifying Neurocognitive Impairments Among Children Living with HIV in Botswana. AIDS Behav. 2022 Aug; 26(8):2758-2767.
Score: 0.012
-
Medical stakeholder perspectives on implementing a computerized battery to identify neurocognitive impairments among youth in Botswana. AIDS Care. 2022 12; 34(12):1513-1521.
Score: 0.011
-
Structural validity of a computerized neurocognitive battery for youth affected by human immunodeficiency virus in Botswana. Psychol Assess. 2022 Feb; 34(2):139-146.
Score: 0.011
-
Tuberculosis symptom screening for children and adolescents living with HIV in six high HIV/TB burden countries in Africa. AIDS. 2021 01 01; 35(1):73-79.
Score: 0.011
-
Tuberculosis among Children and Adolescents at HIV Treatment Centers in Sub-Saharan Africa. Emerg Infect Dis. 2020 12; 26(12).
Score: 0.011
-
Do solidarity and reciprocity obligations compel African researchers to feedback individual genetic results in genomics research? BMC Med Ethics. 2020 11 04; 21(1):112.
Score: 0.011
-
Development of a computerised neurocognitive battery for children and adolescents with HIV in Botswana: study design and protocol for the Ntemoga study. BMJ Open. 2020 08 26; 10(8):e041099.
Score: 0.010
-
Trends in HIV Treatment Adherence Before and After HIV Status Disclosure to Adolescents in Botswana. J Adolesc Health. 2020 10; 67(4):502-508.
Score: 0.010
-
Psychosocial assessments for HIV+ African adolescents: establishing construct validity and exploring under-appreciated correlates of adherence. PLoS One. 2014; 9(10):e109302.
Score: 0.007
-
Early outcomes of darunavir- and/or raltegravir-based antiretroviral therapy in children with multidrug-resistant HIV at a pediatric center in Botswana. J Int Assoc Provid AIDS Care. 2013 Mar-Apr; 12(2):90-4.
Score: 0.006